most common side effects of glp-1 which glp 1 least medications have changed the conversation around weight management Rx Trends: Real-World Data on

The dataset will be made available to the pharmaceutical community to help with drug discovery and development

Starting treatment as soon as possible with FDA-approved medications and potentially changing to retatrutide when it becomes available is a practical approach

Foundayo (orforglipron) produces an average weight loss of 7.5%11.2% in 72 weeks (about a year and 45 months), according to a study of adults with obesity

The social experience of moving from a higher weight to a lower weight often involves receiving more attention, more respect, and more opportunities

Over the last few years, the popularity of Type 2 diabetes medications like Ozempic and Mounjaro are sometimes prescribed off label for weight loss, while Wegovy and Zepbound are approved for the treatment of obesity

This will save state taxpayers millions of dollars annually and ensure that coverage is prioritized for Medicaid recipients who need GLP-1s the most.